BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4

• Press Releases

  Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities

  September 1, 2026

   · 

  3 min read
• 

  Vaccines

  GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modality

  GSK’s vaccine—which targets two primary flu antigens—elicited higher immune responses in both younger and older adults in a mid-stage study. The Phase 3 launch, planned for September, follows the FDA’s recent approval for Moderna’s mRNA flu vaccine.

  September 1, 2026

   · 

  1 min read

   · 

  Heather McKenzie
• Press Releases

  BioViva Announces U.S. Patent for Klotho Gene Therapy Targeting Age-Related Cognitive Decline

  September 1, 2026

   · 

  3 min read
• Press Releases

  BioMarin Announces Close of the Alesta Therapeutics Acquisition

  September 1, 2026

   · 

  4 min read
• Press Releases

  Senticell® Closes Oversubscribed Seed Round to Advance RBC-Based Liquid Biopsy Platform

  September 1, 2026

   · 

  5 min read
• Press Releases

  BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin

  September 1, 2026

   · 

  8 min read
• Press Releases

  Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™

  September 1, 2026

   · 

  2 min read
• 

  Cancer

  Roche finds another oncology gem in Asia with $1.5B B cell disease partnership

  Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.

  September 1, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference

  September 1, 2026

   · 

  2 min read
• Press Releases

  BigHat Biosciences Announces First Patient Dosed in Phase 1 Trial Evaluating BHB810, a Novel CDH17-Directed Antibody-Drug Conjugate, for the Treatment of Gastric Cancer and other Advanced Gastrointestinal Tumors

  September 1, 2026

   · 

  3 min read